Biomedicine & Pharmacotherapy, Journal Year: 2024, Volume and Issue: 180, P. 117534 - 117534
Published: Oct. 13, 2024
Language: Английский
Biomedicine & Pharmacotherapy, Journal Year: 2024, Volume and Issue: 180, P. 117534 - 117534
Published: Oct. 13, 2024
Language: Английский
Frontiers in Microbiology, Journal Year: 2025, Volume and Issue: 16
Published: Feb. 3, 2025
Background Rheumatoid arthritis (RA) is a persistent autoimmune disorder marked by inflammation and joint damage. Although current treatments, such as disease-modifying antirheumatic drugs (DMARDs), help control symptoms, they frequently cause substantial side effects, highlighting the urgent need for safer more effective alternatives. Recent research indicates that gut microbiota might be pivotal in RA development through “gut-joint axis,” presenting novel therapeutic possibilities. Purpose This study seeks to explore potential of traditional Chinese medicine (TCM) compound new bitongling (NBTL) RA, with an emphasis on its capacity regulate suppress angiogenesis via vascular endothelial growth factor (VEGF) signaling pathway. Methods We utilized collagen-induced (CIA) rat model assess impact NBTL. The employed 16S ribosomal DNA (16S rDNA) sequencing analyze composition, machine learning techniques identify characteristic microbial taxa, transcriptomic analysis (GSVA) VEGF findings were further validated deep neural network models vivo / vitro experiments, including western blot, immunofluorescence, miRNA analysis. Results NBTL treatment markedly diminished rats, evidenced reduced expression TNF-α, IL-17, IL-6, ASC synovial tissues. Histopathological confirmed alleviation Five f_Mycoplasmataceae , s_Metamycoplasma_sualvi g_Prevotellaceae_Ga6A1_group identified associated NBTL’s modulation Gene set variation revealed significant downregulation pathway following treatment. Subsequent experiments inhibited receptors, VEGFR1 VEGFR2, along HIF-1α (hypoxia-inducible 1-alpha), thereby reducing angiogenesis. Additionally, upregulated miR-20a-5p miR-223-3p, contributing anti-angiogenic effects. Conclusion exhibits modulating inhibiting These support use promising candidate treatment, emphasizing mechanisms clinical application.
Language: Английский
Citations
1Journal of Ethnopharmacology, Journal Year: 2024, Volume and Issue: 336, P. 118733 - 118733
Published: Aug. 23, 2024
Smilax glabra rhizome has a long history been used for clinical purposes in traditional Chinese medicinal treating various inflammatory conditions. Engeletin
Language: Английский
Citations
4International Journal of Biological Macromolecules, Journal Year: 2025, Volume and Issue: 294, P. 139514 - 139514
Published: Jan. 5, 2025
Language: Английский
Citations
0Drug Design Development and Therapy, Journal Year: 2025, Volume and Issue: Volume 19, P. 303 - 324
Published: Jan. 1, 2025
Huanglian-ejiao decoction (HED) is a Chinese traditional medicinal formula evolved from the Shanghan Lun (Treatise on Febrile Diseases). However, HED ultimate mechanism of action remained indistinct. Therefore, this study aimed to investigate whether could exert anti-inflammatory effects 2,4,6-Trinitrobenzenesulfonic acid (TNBS)-induced colitis (UC) model through regulation CD4+T subsets and gut microbiota. Fifty-eight major compounds in were identified by UPLC-Q-TOF/MS. The therapeutic efficacy UC was assessed evaluating survival rate so on. Flow cytometry employed assay percentages cell. RT-PCR Western blot took advantage detecting transcription factors, inflammatory tight junction proteins. Transcriptome sequencing performed colon tissue 16S rRNA gene enforced intestinal contents. administration enhanced mice, significantly restored body weight, DAI score, weight index, spleen index. effectively reshaped barrier dysfunction, inhibited ratio Th1 Th2 cells, preserved Th2/Th1 Tregs/Th17 balance. Moreover, notably decreased secretion factors related cytokines. Interestingly, also exerts regulatory dysbiosis cumulative plenteous beneficial probiotics like Lactobacillus Bacteroides, while inhibiting overgrowth opportunistic pathogens such as Helicobacter. cell balance, well modulation microbiota HED, provides further experimental evidence for feasibility its treatment UC.
Language: Английский
Citations
0Pharmaceuticals, Journal Year: 2025, Volume and Issue: 18(1), P. 109 - 109
Published: Jan. 16, 2025
Background: Cold-dampness diarrhea (CDD) is a common gastrointestinal disorder in children, characterized by and intestinal barrier dysfunction. Weiling decoction (WLD) frequently used clinical practice to treat CDD, condition triggered multiple factors. However, the molecular mechanisms underlying its therapeutic effects remain poorly understood. Objectives: This study aimed evaluate efficacy of WLD treating CDD elucidate potential mechanisms. Methods: UPLC-HRMS/MS was employed identify chemical constituents absorption components plasma WLD-treated rats. Additionally, rat model established assess through comprehensive approach. To these effects, network pharmacology transcriptomic analyses were performed signaling pathways associated with alleviation. Molecular docking flow cytometry assays subsequently utilized validate identified pathways. Results: A total 223 detected WLD, 49 rats UPLC-HRMS/MS. treatment significantly alleviated symptoms reduced damage, diminished inflammatory response. influenced key genes immune-related revealed strong binding affinities between main targets within Flow cytometry, along analysis cytokines transcription factors, demonstrated that modulated balance Th1/Th2 Th17/Treg cell populations. Conclusions: provides first evidence alleviates regulating These findings offer theoretical basis for future investigations into CDD.
Language: Английский
Citations
0BMC Gastroenterology, Journal Year: 2025, Volume and Issue: 25(1)
Published: Jan. 21, 2025
Abstract Background and aim Ulcerative colitis (UC) is characterized by complex immunological interactions involving CD4 T cell subsets the NLRP3 inflammasome, which influence inflammatory responses. This investigation focused on delineating activation profiles of these components their correlation with disease severity activity, assessing diagnostic implications in UC. Methods We conducted immunohistochemistry ELISA assays to measure markers expression inflammasome UC patients versus controls. Findings were validated using analysis, molecular docking ROC curves. Results displayed increased Th1 (T-bet, TNF-α), Th2 (GATA3, IL-6), Th17 (RORγt, IL-17, IL-22, IL-23) Additionally, cytokines (IL-2 IL-4) significantly elevated severe UC, while Treg (FOXP3, IL-10, TGF-β1) only mild-to-moderate Enhanced activation, indicated NLRP3, Caspase-1, IL-1β levels. These patterns, confirmed through analysis docking, underscored strong correlations among T-bet, GATA3, supporting proposed NLRP3/T-bet/GATA3 axis. axis, along other biomarkers, showed associations severity, Mayo score, UCEIS, demonstrated relatively high value. Conclusion The axis provides a referable strategy for multi-targeted combined treatment may serve as potential biomarkers enhancing accuracy guiding therapy.
Language: Английский
Citations
0Journal of Ethnopharmacology, Journal Year: 2025, Volume and Issue: unknown, P. 119457 - 119457
Published: Feb. 1, 2025
Language: Английский
Citations
0Biomarkers, Journal Year: 2025, Volume and Issue: 30(1), P. 10 - 22
Published: Jan. 2, 2025
Colorectal cancer (CRC) is a substantial global health burden, with treatment outcomes significantly influenced by the interaction between immune system and tumor microenvironment. This study aims to investigate role of peripheral blood cell subpopulations, particularly CD8+ CD28+ T cells, in predicting response metastatic CRC patients receiving bevacizumab combined chemotherapy. A cohort 45 was analyzed. Flow cytometry utilized assess subpopulations. Higher counts were associated better responses, including improved objective rates. In murine model, combination therapy inhibited growth enhanced function. These findings highlight importance cells as potential biomarkers for CRC. They also suggest that bevacizumab, when chemotherapy, can modulate function improve clinical efficacy.
Language: Английский
Citations
0Frontiers in Cellular and Infection Microbiology, Journal Year: 2025, Volume and Issue: 15
Published: March 3, 2025
Inflammatory Bowel Disease (IBD) is an autoimmune disease characterized by chronic relapsing inflammation of the intestinal tract. Gut microbiota (GM) and CD4 + T cells are important in development IBD. A lot studies have shown that GM their metabolites like short-chain fatty acids, bile acids tryptophan can be involved differentiation through various mechanisms, which turn regulate immune homeostasis IBD patients. Therefore, regulating may a potential therapeutic direction for treatment Many Traditional Chinese Medicine (TCM) formulas some herbal extracts affect cell its metabolites. In this review, we mainly focus on role correlation with We also summarize current research progress regulation process TCM.
Language: Английский
Citations
0Molecular Biology Reports, Journal Year: 2025, Volume and Issue: 52(1)
Published: April 7, 2025
Language: Английский
Citations
0